FAQs – on Notification: Marketer of drugs

FAQs – on Notification: Marketer of drugs

1213
FAQs
Picture: Pixabay
Lalit Kr. Goel

Last Updated on July 24, 2021 by The Health Master

FAQs – on Notification: Marketer of drugs

Ministry of Health and Family Welfare has amended the Drugs and Cosmetics Rules, 1945 vide notification No. G.S.R. 101(E) dated 11-02-2020 regarding the Marketer. These rules may be called the Drugs and Cosmetics (Amendment) Rules, 2020.

Gazette of India Notification

To download the notification, click here

Ad Marketing
Picture: Pixabay

Q1.      Weather Medical Representative is responsible for the quality of dugs of the manufacturer or marketer as per above notification.

Ans:    No, as per notification Medical Representative is not responsible for the quality of drugs. 

Q2.      Shall Marketer be responsible for the quality of drugs ?

Ans:    Marketer shall be responsible for the quality of drugs as well as other regulatory compliances along with the manufacturer.

Q3.      From which date this notification shall come into force ?

Ans:    This notification shall come into force on the 1st day of March, 2021.

Q4.      Whether an agreement is required between the Manufacturer and Marketer ?

Ans:    Yes, an agreement is required between the manufacture and the marketer.

Q5.      Can marketer label or affix his name and address on the labels of the drug ?

Ans:    Yes, Marketer can label or affix his name and address on the labels of the drug.



Subscribe for daily free updates

Telegram
WhatsApp
Facebook
LinkedIn

Enter your email address:

Delivered by FeedBurner